Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment

(1) Background: At diagnosis, multiplemyeloma risk estimation includes disease burden, end-organ damage, and biomarkers, with increasing emphasis on genetic abnormalities. Multicolor flow cytometry (MFC) is not always considered in risk estimation. We demonstrate associations found between genetic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Radzevičius, Mantas, Dirsė, Vaidas, Klimienė, Indrė, Matuzevičienė, Rėda, Kučinskienė, Zita Aušrelė, Pečeliūnas, Valdas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498268/
https://www.ncbi.nlm.nih.gov/pubmed/36140450
http://dx.doi.org/10.3390/diagnostics12092049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498268/
https://www.ncbi.nlm.nih.gov/pubmed/36140450
http://dx.doi.org/10.3390/diagnostics12092049

Ejemplares similares